Lexicon Pharmaceuticals Schedules Third-Quarter Results for November 5
Lexicon Pharmaceuticals said it will report third-quarter 2026 financial results on November 5, 2026.
Related stories
MRK Reports Fiscal Q3 Net Loss
MRK reported a fiscal third-quarter net loss attributable to shareholders, down 103.34% year over year.
M impact | EQUITY | Oct 30, 2026, 05:45 AM UTC
MA Reports Fiscal Q3 Profit of 129亿美元, Up 18.24%
MA reported fiscal third-quarter profit attributable to shareholders of 129亿美元, up 18.24% year over year, with basic EPS of 14.61美元.
M impact | EQUITY | Oct 30, 2026, 05:45 AM UTC
MO Reports Fiscal 2026 Q3 Profit, Up 20.05%
MO reported fiscal third-quarter profit attributable to shareholders up 20.05% year over year, and basic EPS.
M impact | EQUITY | Oct 30, 2026, 05:45 AM UTC
LLY Reports Fiscal Q3 Profit Growth of 49.56%
The report states fiscal third-quarter profit attributable to shareholders rose 49.56% year over year and basic EPS was reported.
M impact | EQUITY | Oct 30, 2026, 05:42 AM UTC
Viasat Leads Space Stocks as SPCX Falls 5% in October
Viasat was the group's only gainer over the past month, while SpaceX fell 5%. The report compares performance with AST SpaceMobile, Rocket Lab and Planet Labs.
M impact | EQUITY | Oct 30, 2026, 05:40 AM UTC
PL Capital Upgrades Hindustan Unilever to Buy
PL Capital upgraded Hindustan Unilever to a Buy rating, citing valuation and growth in consumer stocks.
M impact | EQUITY | Oct 30, 2026, 05:31 AM UTC